AOD-9604 (Anti-Obesity Drug fragment 9604) is a modified peptide fragment of human growth hormone (HGH 176-191). Unlike full HGH, AOD-9604 does not affect blood sugar or IGF-1 levels but retains the potent fat-burning properties of growth hormone. Research highlights its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage), making it a promising peptide for weight management and metabolic research. Why AOD-9604 Stands Out AOD-9604 was specifically designed to isolate the fat-reducing region of HGH while removing unwanted growth-promoting effects. This makes it ideal for metabolic and obesity-related research: Lipolysis Activator: Stimulates fat breakdown Lipogenesis Inhibitor: Prevents new fat accumulation Safe Profile: Does not raise blood sugar or IGF-1 Key Benefits of AOD-9604 ✅ Promotes fat loss & weight management ✅ Reduces abdominal and visceral fat ✅ Does not impact blood sugar or insulin ✅ Supports metabolic health research ✅ Potential cardiovascular and joint health benefits (cartilage repair noted in studies) Application & Dosage Guidelines Dosage Range (Research Use): 250 mcg – 1 mg daily (varies by study) Administration: Subcutaneous injection (research use only) Frequency: Daily or as per research protocol Reconstitution: Mix with bacteriostatic or sterile water for injection Storage: Keep refrigerated after mixing (up to 10 days) ⚠️ Safety & Side Effects All dosing information is for research purposes only and not for human consumption unless prescribed by a licensed professional. Possible dose-dependent effects may include: Occasional mild headache or nausea Redness or irritation at injection site Rare fatigue or mild digestive upset Clinical research suggests AOD-9604 may support weight loss, fat metabolism, and cartilage repair without the risks associated with full growth hormone therapy.